2-(2-HYDROXYETHYLAMINO)-N-(2-CHLOROPHENYL)ACETAMIDE, 95.0%, 5g

3-Cyclobutyl-1H-pyrazol-5-amine, 95.0%, 250mg

2-(Difluoromethyl)-3-fluoropyridin-4-amine hydrochloride, 97.0%, 250mg

N-tert-Butyl-succinamic acid, 95.0%, 1g

4-ACETYL-2-METHYL-2H-INDAZOLE, 95.0%, 250mg

6-Bromo-3-hydroxyisoquinoline, 98.0%, 25g

O-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N',N'-tetramethyluronium Tetrafluoroborate>98.0%(HPLC)5g

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)tetradecanoic acid, 95%, 5g

CEFMETAZOLE SODIUM, 98%, 100mg

2-(4-Fluorophenyl)propan-2-amine hydrochloride, 95.0%, 5g

1H-PYRAZOLO[3,4-C]PYRIDINE-7-CARBOXYLIC ACID, 95.0%, 250mg

(1S,2S)-N1,N2-BIS(2-(BIS(3,5-DIMETHYLPHENYL)PHOSPHINO)BENZYL)CYCLOHEXANE-1,2-DIAMINE, 95%, 250mg

Stéarate de butyle, pour la synthèse, 2,5 L, emballage en verre